Header image

Session I: Oral Abstracts

Tracks
.
Thursday, September 7, 2017
1:30 PM - 2:50 PM
Manhattan Ballroom

Speaker

Dr Sunil Solomon
Associate Professor Of Medicine
Johns Hopkins University School Of Medicine

DOT of Sofosbuvir/Ribavirin +/- Peginterferon with Minimal Monitoring for the Treatment of Hepatitis C in People who Use Drugs in Chennai, India (C-DOT)

1:30 PM - 1:45 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Dr. Sunil Solomon is an Associate Professor of Medicine and Epidemiology at the Johns Hopkins University School of Medicine. He has been working with drug using populations in India since 2004. He was instrumental in establishing MIDACS, one of the first longitudinal cohorts of drug users in India. His research is focussed on improving HIV and HCV related outcomes among substance using populations across India.
Dr Phillip Read
Director
Kirketon Road Centre

Delivering Direct Acting Antiviral Therapy to Highly Marginalised Populations in an Integrated Primary Health Care Setting

1:45 PM - 2:00 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Dr Phillip Read is the director of the Kirketon Road Centre, a primary health care facility in Sydney involved in the prevention treatment and care of viral hepatitis among people who inject drugs, sex workers and at-risk young people
Professor Of Medicine And Psychiatry Alain Litwin
Professor Of Medicine And Psychiatry
Albert Einstein College Of Medicine And Montefiore Medical Center

The PREVAIL Study: Intensive Models of HCV Care for People Who Inject Drugs

2:00 PM - 2:15 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Agenda Item Image
Dr. Natasha Martin
Associate Professor
University of California San Diego, United States

HCV Treatment with Direct-Acting Antivirals in India is Cost-Saving

2:15 PM - 2:30 PM

Abstract

Biography

Natasha K. Martin , DPhil, is an Associate Professor in the Division of Global Public Health in the Department of Medicine at the University of California San Diego. She is also an Honorary Senior Lecturer at the University of Bristol. Dr. Martin is an infectious disease and economic modeler. Dr. Martin’s work focuses on using dynamic epidemic modeling to evaluate the impact and cost-effectiveness of HIV, HCV, and HBV prevention interventions among high risk populations such as people who inject drugs, men who have sex with men, and incarcerated populations. She is one of the leading researchers examining the potential impact and cost-effectiveness of HCV treatment as prevention.
Kyle Prochno
Research Coordinator
Icahn School Of Medicine At Mount Sinai

The Impact Of Alcohol Dependence On Hcv Treatment Initiation In Hiv/Hcv Coinfected Patients Within A Randomized Controlled Trial Investigating A Psychosocial Behavioral Intervention

2:30 PM - 2:35 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Clinical Research Coordinator at Mount Sinai Hospital/Icahn School of Medicine at Mount Sinai in Manhattan. Aspiring physician/scientist; completed Post-baccalaureate Program at Columbia University in 2016.
Mr Arshia Alimohammadi
Clinical Researcher
Vancouver Infectious Diseases Centre

All-Oral Anti-HCV Therapy in Injecting Drug Users: Updated Real World Data

2:35 PM - 2:40 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Mr. Alimohammadi is a Clinical Researcher at VIDC, and is Completing his Bsc. in Microbiology and Immunology at the University of British Columbia. His work at VIDC mainly focuses on tackling HCV in vulnerable populations like people who use drugs.
Dr. Susan Nouch
Family Physician
University of British Columbia/Vancouver Coastal Health

Hepatitis C Treatment by Primary Care Teams in Inner-City Community Health Clinics: A Prospective Cohort Study

2:40 PM - 2:45 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Dr. Susan Nouch is a Family Physician based in Vancouver, Canada. She works with an multidisciplinary Hepatitis C treatment program in an inner-city community health center where she also practices addiction medicine. She is currently completing a Family Medicine research fellowship with the University of British Columbia. She is interested in the expanded role of Family Physicians in the management of Hepatitis C in vulnerable populations.
Raphael Schubert
Head of Nursing Department Suchthilfe Wien gGmbH
Gilead Sciences Ltd

Highly Effective HCV-Therapy and Low Rate of Reinfection in Persons who Inject Drugs and Receive Opioid Agonist Therapy

2:45 PM - 2:50 PM

Abstract

Speaker Presentation

Video Presentation

Biography

In 2015 Raphael Schubert started to work at the nursing department of the “Suchthilfe Vienna”. Since November 2016 he is the head of the nursing department and the organizational manager of the outpatient clinic. In addition, since 2015 he is involved in the hepatitis project. Educational Background: Bachelor of Health Science Registered Nurse
loading